Literature DB >> 31784737

Nod2 Protects the Gut From Experimental Colitis Spreading to Small Intestine.

Ziad Al Nabhani1, Dominique Berrebi1,2, Christine Martinez-Vinson2, Nicolas Montcuquet3,4, Chrystele Madre2, Maryline Roy1, Eric Ogier-Denis1, Monique Dussaillant1, Nadine Cerf-Bensussan3,4, Habib Zouali5, Fanny Daniel1, Frédérick Barreau1,6, Jean-Pierre Hugot1,2.   

Abstract

BACKGROUND AND AIMS: Nucleotide oligomerization domain 2 [NOD2] mutations are key risk factors for Crohn's disease [CD]. NOD2 contributes to intestinal homeostasis by regulating innate and adaptive immunity together with intestinal epithelial function. However, the exact roles of NOD2 in CD and other NOD2-associated disorders remain poorly known.
METHODS: We initially observed that NOD2 expression was increased in epithelial cells away from inflamed areas in CD patients. To explore this finding, Nod2 mRNA expression, inflammation, and cytokines expression were examined in the small bowel of wild-type [WT], Nod2 knockout and Nod2 mutant mice after rectal instillation of 2,4,6-trinitrobenzene sulphonic acid [TNBS].
RESULTS: In WT mice, Nod2 upregulation upstream to rectal injury was associated with pro-inflammatory cytokine expression but no overt histological inflammatory lesions. Conversely, in Nod2-deficient mice the inflammation spread from colitis to ileum and duodenum.
CONCLUSIONS: Nod2 protects the gut from colitis spreading to small intestine.
Copyright © 2019 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  CD4+ T cells; Crohn’s disease; Nod2; gut barrier; inflammatory cytokines

Mesh:

Substances:

Year:  2020        PMID: 31784737     DOI: 10.1093/ecco-jcc/jjz196

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  1 in total

1.  Intestinal alkaline phosphatase (IAP, IAP Enhancer) attenuates intestinal inflammation and alleviates insulin resistance.

Authors:  Chenzhe Gao; Marwa Yagoub Farag Koko; Mingxing Ding; Weichen Hong; Jianping Li; Na Dong; Mizhou Hui
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.